Related Experiment Video

Updated: Jul 9, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice

C-M Liu1, Z Yang, C-W Liu

  • 1Molecular Virology Research Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Gene Therapy
|November 23, 2007
PubMed

Insights

Inactivating myostatin with RNA oligonucleotides promotes muscle growth in normal and cachectic mice. This antisense strategy shows potential for treating muscle wasting conditions by targeting myostatin expression.

Area of Science:

  • Muscle biology and regenerative medicine
  • Molecular genetics and therapeutic oligonucleotides

Background:

  • Myostatin acts as a negative regulator of muscle growth (myogenesis).
  • Inhibiting myostatin activity is known to stimulate muscle hypertrophy.

Purpose of the Study:

  • To investigate the therapeutic potential of modified RNA oligonucleotides targeting myostatin mRNA.
  • To evaluate the efficacy of myostatin inhibition in normal and cancer cachexia mouse models.

Main Methods:

  • Administration of modified RNA oligonucleotides designed to suppress myostatin mRNA expression.
  • Assessment of muscle growth and myostatin expression levels in vivo.
  • Analysis of the MyoD pathway activation in response to myostatin inhibition.

Main Results:

  • RNA oligonucleotides effectively suppressed myostatin expression in mice.
  • Significant muscle growth was observed in both normal and cachectic mice.
  • Myostatin inhibition via RNA oligonucleotides led to a notable upregulation of MyoD expression, suggesting pathway involvement.

Conclusions:

  • Antisense strategy using RNA oligonucleotides is a feasible approach for treating muscle wasting conditions.
  • Myostatin inhibition demonstrates therapeutic potential for conditions characterized by muscle loss, including cancer cachexia.

More Related Videos

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...